News | News By Subject | News by Disease News By Date | Search News

Bladder cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Merck & Co. (MRK)'s Immuno-Oncology Star Racks Up Two New Bladder Cancer Approvals     5/19/2017
Genentech (RHHBY)'s Top Cancer Prospect Flunks Phase III Test     5/12/2017
AstraZeneca PLC (AZN) Hits Milestone With Approval of Potential Bladder Cancer Blockbuster     5/3/2017
Sanofi Pasteur (SASY.PA) Abandons Bladder Cancer Drug     11/18/2016
Study Stopped Early as Merck & Co. (MRK)'s Immunotherapy Drug Wows in Bladder Cancer Trial     10/27/2016
Spectrum Pharma (SPPI) Allegedly Hid a Key Detail From a Meeting With the FDA     9/19/2016
Bristol-Myers Squibb (BMY)'s Miracle Drug Opdivo Receives Yet Another Breakthrough Designation     6/28/2016
ASCO2016: Genentech (RHHBY)'s TECENTRIQ Shrank Tumors in People with Previously Untreated Advanced Bladder Cancer     6/6/2016
Genentech (RHHBY) Nabs FDA Approval of First New Bladder Cancer Drug in 30 Years     5/20/2016
Roche (RHHBY)'s Pharma Head Believes Its First Cancer Immunotherapy Will Win FDA Approval Soon     4/19/2016
Genentech (RHHBY)'s Bladder Cancer Drug Gains Priority Review by the FDA     3/16/2016
AstraZeneca PLC (AZN) Continues Its Immuno-Oncology Roll, Durvalumab Gets Breathrough Designation for Bladder Cancer     2/18/2016
FDA Lifts Heat Biologics Partial Clinical Hold     2/10/2016
Roche (RHHBY) Encouraged by Mid-Stage Atezolizumab Bladder Cancer Data     1/8/2016
Merck KGaA (MKGAF.PK), Pfizer (PFE) Accelerate Immuno-Oncology Drug Avelumab into Phase III Ovarian and Bladder Cancer Trials     12/22/2015

News from Around the Web
Roche (RHHBY)’s Tecentriq Hits Trouble with NICE in Bladder Cancer     8/3/2017
Coroner Alarmed By Lack Of Warning On Pfizer (PFE) Drug Champix     11/21/2016
Mycobacterium In Olive Oil For Cancer Treatment, Universitat Autònoma de Barcelona Study     6/23/2016
Newcastle University Study Could Lead To Approval Of Test For Bladder Cancer     1/18/2016
No Link Found Between Bladder Cancer And Popular Diabetes Meds, University of Dundee Study     12/8/2014
Source Of Most Cases Of Invasive Bladder Cancer Identified, Stanford University School of Medicine Study     4/22/2014
Three of Four Cases of Bladder Cancer Display Mutations in the Same Gene, National Cancer Research Centre Study     9/11/2013
High Levels of Vitamin D in Plasma Protects Against Bladder Cancer, Spanish National Cancer Research Centre Study     10/31/2012
Selenium May Protect Against Bladder Cancer, Study Published in Cancer Epidemiology, Biomarkers & Prevention     9/1/2010
Well-Done Meat Doubles Bladder Cancer Risk, University of Texas Study     4/20/2010
Variation In Prostate Stem Cell Antigen Gene Raises Bladder Cancer Risk, University of Texas MD Anderson Cancer Center Study     8/20/2009
Intensive Early Treatment Doesn't Help Bladder Cancer Survival, University of Michigan Health System Study     4/8/2009
Frankincense Oil 'Could Be Alternative Treatment For Bladder Cancer', University of Oklahoma Study     3/19/2009
Investigational Treatment for Deadly Bladder Cancer, Developed Using New Research Model, by Columbia University Medical Center Faculty-Led Team     3/19/2009
Selenium May Prevent High Risk-Bladder Cancer, Dartmouth Medical School Study     12/8/2008

Press Releases
Rexahn Pharmaceuticals, Inc. (RNN) Presents Preliminary Efficacy Data From The Ongoing Phase IIa Clinical Trial Of RX-3117 In Advanced Bladder Cancer At The 2017 European Society For Medical Oncology (ESMO) Congress     9/11/2017
Five Prime (FPRX) Presents Preclinical Research Data On Novel B7-H4 Therapeutic Antibody At ESMO 2017 Congress     9/11/2017
European Commission (EC) Approves Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Certain Patients With Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer     9/5/2017
Bristol-Myers Squibb (BMY) And Daiichi Sankyo Announce Research Collaboration To Evaluate Opdivo (Nivolumab) And DS-8201 In HER2-Expressing Breast And Bladder Cancers     8/29/2017
Spectrum Pharma (SPPI) Announces Initiation Of The Registrational Phase III Trial Of Qapzola (Apaziquone) In Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)     8/14/2017
H3 Biomedicine And University of British Columbia Scientists Report Preclinical Data Describing Immune Evasion Mechanism In Muscle-Invasive Bladder Cancer     7/24/2017
EMA's CHMP Recommends Approval For Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Certain Patients With Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer     7/21/2017
numares AG Achieves Key Milestone: Identifies Candidate Metabolomic Network For Bladder Cancer Diagnostics     7/13/2017
MDxHealth, Inc. (MXDHF) Launches Assuremdx For Bladder Cancer Liquid Biopsy Test     7/6/2017
MDxHealth, Inc. (MXDHF) Launches AssureMDx For Bladder Cancer Liquid Biopsy Test     7/6/2017
Eleven Bio (EBIO) To Collaborate With AstraZeneca PLC (AZN) And NCI On Development Of Viciniumtm In Combination With Durvalumab For The Treatment Of Non-Muscle Invasive Bladder Cancer     6/6/2017
Rexahn Pharmaceuticals, Inc. (RNN) Presents Preliminary Efficacy Data From The Ongoing Phase IIa Clinical Trial Of RX-3117 In Metastatic Bladder Cancer At The ASCO 2017 Annual Meeting     6/5/2017
American Society for Radiation Oncology Release: Combined Modality Treatment Could Be First Course Of Treatment For Muscle-Invasive Bladder Cancer, New Study Shows     5/31/2017
i-Health, Inc. Release: New AZO Product Addresses Bladder Control In Two Ways     5/23/2017
IMFINZI (Durvalumab) Approved For Previously Treated Patients With Advanced Bladder Cancer, Available Immediately At BioLogics     5/22/2017